Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

Novartis is set to launch its one-off gene ... process (AMNOG) in Germany and this will be ongoing in the coming months, potentially making Germany one of the first countries to make gene ...

Dr Diego Correa is global head of the Cell and Gene Therapy Center of Excellence at IQVIA. Bringing more than two decades of basic and translational research experience in cell therapy ...

Your body remembers what your mind forgets. Discover how trauma lives in your cells and the breakthrough therapies that can ...

Reza Zafarqandi and his Indian and Uzbek counterparts have explored the potential for the expansion of health cooperation, ...

Following massive layoffs and cuts at the FDA, Makary’s plan for the agency is yet to fully unfold. But he has hinted at what ...

("Shineco" or the "Company"; NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, announced today that on April 22, 2025, its subsidiary, Shineco Life ...

One assay applies to bioprocesses that use the HEK293 human embryonic kidney cell line, often used in gene therapy development.

If administered early, gene therapy has the potential to change the medical history of children born with metachromatic ...

Hathway’s technology uses natural epigenetic processes to dial gene activity up or down, rather than rewriting the genetic code. The company is using this to develop therapies for rare diseases and ...